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In this report we present the case of a 77-yr-old man who underwent resection of the upper
lobe of the left lung for a carcinoma, six weeks after percutaneous transluminal coronary
angioplasty (PTCA) with stenting of the left anterior descending (LAD) and circum¯ex
coronary arteries. Antiplatelet therapy with clopidogrel was interrupted two weeks before
surgery to allow for epidural catheter placement and to minimize haemorrhage. The surgical
procedure was uneventful. In the immediate postoperative period, however, the patient
suffered severe myocardial ischaemia. Emergency coronary angiography showed complete
thrombotic occlusion of the LAD stent. In spite of successful recanalization, reinfarction
occurred and the patient died in cardiogenic shock. Prophylactic preoperative coronary
stenting may put the patient at risk of stent thrombosis if surgery cannot be postponed for
three months. In such cases, other strategies such as perioperative b-blockade for preoperative
cardiac management should be considered.
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Patients with severe coronary artery disease (CAD) sched-
uled for urgent major surgery such as for cancer are a
particular challenge for anaesthetists: one can proceed with
surgery with the risk of postoperative cardiac complications,
or coronary revascularization might be performed ®rst and
surgery postponed. However, delay can be undesirable
because of the risk of tumour progression.
In patients with severe CAD, percutaneous transluminal
coronary angioplasty (PTCA) before surgery may reduce
postoperative morbidity and mortality.1±3 The use of
intracoronary stents has modi®ed the situation. Kaluza and
colleagues4 reported that PTCA with coronary stenting
increased the risk of stent thrombosis and myocardial
infarction if surgery was performed within 6 weeks. The
new ACC/AHA guidelines propose a 4±6-week interval
between PTCA with stenting and non-cardiac surgery "to
allow 4 full weeks of dual antiplatelet therapy and re-
endothelialization of the stent to be completed, or nearly
so".5
We present a case of early non-cardiac surgery performed
after coronary revascularization by balloon angioplasty and
stenting, where the recommended delay was respected.
Case report
A nodular lesion, highly likely to be a primary tumour, was
detected in the upper lobe of the left lung of a 77-yr-old
man; mediastinoscopy with lobe resection was indicated. He
had arterial hypertension, hypertensive cardiomyopathy and
chronic renal insuf®ciency (serum creatinine 190 mmol
litre±1, creatinine clearance 29 ml min±1). He had dyspnoea
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on exertion (NYHA grade II) and angina (Canadian
Cardiovascular Society class II).
Baseline ECG (Fig. 1A), bronchoscopy, spirometry and
lung volumes were all within normal limits. Exercise testing
con®rmed ischaemic heart disease, with retrosternal pain
accompanied by a 0.2 mV depression of the ST segments in
leads V5 and V6 at 96% of the theoretical maximal heart
rate. Coronary angiography showed severe two-vessel
disease with 90% stenosis of the proximal and middle
parts of the circum¯ex coronary artery (Cx), 75% stenoses
of the proximal and middle parts of the left anterior
descending coronary artery (LAD) and 95% stenosis of a
diagonal branch of the LAD (Fig. 2). Left ventricular
function was preserved, with an ejection fraction of 0.65.
Both Cx and LAD were dilated and stented, with two stents
in each of the coronary arteries (two Jomed stents in the Cx
and two Velocity stents in the LAD) (Fig. 3). Since the
diagonal branch was considered a minor coronary artery it
was not dilated. The patient was treated with clopidogrel 75
mg day±1 and aspirin 300 mg day±1 for 4 weeks, followed by
aspirin 300 mg day±1 alone for 2 more weeks. Clopidogrel
Fig 1 (A) Preoperative ECG; (B) 2 h after surgery; acute anterior myocardial infarction; (C) arrival in the intensive care unit after recanalization;
(D) postoperative day 2, left bundle branch block with hypotension and cardiogenic pulmonary oedema.
Fig 2 Preoperative coronary angiography showing 75% stenosis of the
proximal and middle parts of the left anterior descending coronary artery
(white triangles) and 95% stenosis of a diagonal branch (black triangle)
(60% left anterior oblique view with 20% cranial inclination).
Fig 3 Restoration of ¯ow in the left anterior descending coronary artery
after successful recanalization (black triangle) (60% left anterior oblique
view with 20% cranial inclination).
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was stopped 2 weeks before surgery to allow the use of an
epidural catheter and to reduce the risk of surgical
haemorrhage.
Six weeks after coronary revascularization, the patient
was admitted for surgery. An epidural catheter was inserted
in the T4±T5 interspace. General anaesthesia was induced
with propofol 150 mg, fentanyl 300 mg and vecuronium 8
mg. Tracheal intubation was with a 39-French right-sided
double-lumen tracheal tube. Supplemental fentanyl 200 mg
boluses were given at the times of tracheal intubation and
surgical incision. Anaesthesia was maintained with des¯ur-
ane, and intraoperative analgesia was provided with a
continuous epidural infusion of bupivacaine 0.5% 6 ml h±1
and a remifentanil infusion adjusted as needed. Monitoring
included a ®ve-lead ECG with continuous ST segment
analysis, oesophageal temperature, pulse oximetry, FIO2 and
FE¢CO2 and invasive arterial pressure measurement using a
3F cannula in the right radial artery. Biopsies taken during
mediastinoscopy were tumour free, and a left upper lobe
resection with ipsilateral lymph node resection was carried
out using a posterolateral incision. The surgical procedure
took 210 min and was uneventful. The tumour was an
epidermoid carcinoma with hilar lymph node metastases
(T1N1M0). The patient was extubated in the operating
theatre. During surgery, the patient's circulation remained
stable and no signs of myocardial ischaemia were seen on
ST segment analysis.
On arrival in the recovery room, the patient was in pain
and epidural analgesia was given, with a total of 8 mg of i.v.
morphine; labetalol 20 mg was given i.v. to suppress the
responses to pain (arterial pressure 200/90 mm Hg, heart
rate 116 beats min±1), after which the patient became pain
free and cardiovascular measures improved (arterial pres-
sure 150/90 mm Hg, heart rate 76 beats min±1). One h later,
however, the patient developed sudden severe retrosternal
pain and dyspnoea. Conventional ECG displayed Pardee
curves up to 0.6 mV above baseline in leads V1±V4
(Fig. 1B). The patient was given supplemental oxygen;
acetylsalicic acid 500 mg, esmolol boluses up to 40 mg and
morphine 8 mg were administered i.v. An infusion of
nitroglycerine was started at 2 mg kg±1 min±1. Arterial
pressure and heart rate remained stable at 140/80 mm Hg
and 80 beats min±1, respectively.
Emergency coronary angiography showed occlusion of
the proximal LAD stent (Fig. 4) but there was no ¯ow
reduction in the Cx stents. After successful recanalization of
the proximal LAD stent, several thrombi and a distal
occlusion were found in the LAD (Fig. 5). Because of the
risk of postoperative haemorrhage, intracoronary thrombo-
lytic therapy was not given, nor treatment with a IIb-IIIa
receptor inhibitor (abciximab).
After angiography, the patient was haemodynamically
stable and was transferred to the intensive care unit (ICU).
The ECG on admission showed signs of improvement, with
the ST segment 0.2 mV above baseline in V2 and V3, and
0.1 mV in V4 (Fig. 1C). Serum troponin-I values increased
from below 0.03 mg litre±1 at the time of the acute event in
the recovery room to 0.18 mg litre±1 2 h later at arrival in the
ICU (normal range <0.03 mg litre±1). Anticoagulation was
with heparin titrated to an activated partial thromboplastin
time (aPTT) of 30±40 s, and oral clopidogrel 300 mg was
given once as a single dose followed by 75 mg daily. The
Fig 4 Postoperative coronary angiography showing complete occlusion of
the left anterior descending coronary artery stent (black triangle) (60%
left anterior oblique view with 20% cranial inclination).
Fig 5 After recanalization of left anterior descending coronary artery
stent (black triangle), multiple-staged thrombi (white triangles), stable
95% lesion of the diagonal branch (arrow) (60% left anterior oblique
view with 20% cranial inclination).
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patient remained haemodynamically stable throughout the
night and the following day, without supportive therapy.
During the second night after surgery the patient
developed left bundle branch block (Fig. 1D) and cardiac
failure (arterial pressure 83/48 mm Hg, heart rate 105 beats
min±1, central venous pressure 16 cm H2O) with pulmonary
oedema. Transthoracic ECG showed extensive antero±
septo±apical akinesia and hypokinesia in the other segments
of the left ventricle. Ejection fraction was estimated at 0.20.
Troponin-I levels exceeded 100 mg litre±1, con®rming a
large myocardial infarction.
In spite of increased anticoagulant therapy (heparin
titrated to aPTT of 45±55 s), dobutamine 8 mg kg±1 min±1
and norepinephrine 0.4 mg kg±1 min±1, the patient's clinical
status deteriorated, with tachypnoea (24 bpm) and tachy-
cardia (131 beats min±1). Arterial pressure was 101/58 mm
Hg. A pulmonary artery catheter showed pulmonary
hypertension (39/24 mm Hg) and increased pulmonary
capillary wedge pressure (mean 21 mm Hg). Cardiac index
was 2.17 litre min±1 m±2. In view of the patient's advanced
age, the extent of myocardial infarction, the severe left
ventricular dysfunction and the poor prognosis of the
malignant lung disease (T1N1M0), haemodynamic and
respiratory support was not increased and the patient died
in asystole on the fourth day after surgery.
Discussion
Early in-stent thrombosis is a complex phenomenon. First,
during the atherosclerotic process, coronary endothelial
cells change from an antithrombotic to a prothrombotic
phenotype.6 Second, immediately after balloon dilation,
there is an in¯ammatory reaction with enhanced expression
and disposition of prothrombotic factors on the injured
endothelium.7 This endothelial injury is exaggerated if an
intracoronary stent is placed,8 partly because higher in¯a-
tion pressures and oversized balloons are used for stent
deployment. This injury and subsequent in¯ammation cause
loss of endothelial barrier function for 3 months after
coronary stenting.9 Third, the stent itself causes in¯amma-
tory and prothrombotic changes: a ®brinogen layer imme-
diately covers the surface of the stent10 and major platelet
activation is induced.11 Fourth, the type of stent used may
also cause thrombosis. The culprit stent in the case
described was a bare-metal stent known to cause severe
local in¯ammation.12 Finally, in this particular patient, the
in¯ammatory response after surgery and activation of the
coagulation system, as well as a possible coagulopathy
linked to the underlying malignant process, could have
contributed to the thrombosis. Immediately after surgery
this patient also had severe pain with hypertension and
tachycardia resulting from insuf®cient afferent and sympa-
thetic epidural blockade. A more ef®cient cardiac sym-
pathectomy might have helped prevent these adverse
cardiac events.
Recent research has focused on the long-term conse-
quences of endothelial injury and its in¯ammatory reaction,
leading to neointimal hyperplasia and late in-stent steno-
sis.13 This occurs in 15±30% of patients within months of
intracoronary stenting and requires reintervention. New
anti-in¯ammatory and antimitogen drugs, as well as new
techniques such as intracoronary radiation, are being tested,
with contradictory results.14 Stent technology is also
advancing, and new types of intracoronary stents are
being used, including the cytostatic eluting stents.
Designed to prevent neointimal hyperplasia in the stent's
lumen, these stents effectively inhibit cellular proliferation
on the stent wall, delaying intimal healing and increasing
®brinogen deposition.15 Patients treated with such stents
will need longer dual antiplatelet therapy. The conse-
quences of these new stents for a patient having surgery are
unclear.
Compared with simple balloon angioplasty, the intracor-
onary stent offers better short- and long-term outcome in
patients not having surgery.16 For surgical patients, PTCA
with balloon dilation may reduce the risk of perioperative
cardiac complications.2 3 17 No studies, however, have
compared preoperative PTCA with and without stenting.
Recent reports of adverse outcomes4 18 and the present case
suggest that non-cardiac surgery soon after coronary
stenting is associated with a major risk of postoperative
myocardial ischaemia, even if the recommended interval of
6 weeks is respected. There are no prospective randomized
trials de®ning the minimum safe delay between PTCA with
stenting and subsequent surgery. Therefore, treatment has to
be guided by basic science and observational studies. A 3-
month delay between PTCA with stenting and any surgical
intervention has been recently recommended to minimize
the risk of in-stent thrombosis.19 However, in the case
described here, the pulmonary lesion turned out to be a
potentially operable lung cancer, and a 3-month delay after
coronary revascularization may have been dif®cult to justify
because of the risk of tumour progression. Comparing the
images of the pre- and postoperative coronarographies we
can also see that the high-grade stenosis of the diagonal
branch remained unchanged throughout the perioperative
period. Although it is a critical stenosis, it can be considered
as a stable coronary lesion because it has an intact
endothelium. An incompletely re-endothelialized stent, on
the other hand, is an unstable coronary lesion and should be
treated as such (i.e. with aggressive antiplatelet therapy).
We stopped clopidogrel 2 weeks before the operation, as
recommended5 to prevent surgical haemorrhage and to
allow placement of an epidural catheter. However, 6 weeks
may not be long enough for re-endothelialization to be
completed. In retrospect, continuation of clopidogrel until
the day of surgery, forgoing the advantages of epidural
analgesia and accepting an increased risk of bleeding, might
have been a better choice.
What alternative strategies exist for the perioperative
management of such patients? First, aggressive haemody-
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namic management with perioperative b-blockade without
PTCA or stenting may be considered. This approach has
been advocated by six publications summing a total of 502
patients receiving perioperative b-blockade. Only three of
these studies were randomized (201 b-block patients in
total) and only two were outcome studies (158 b-block
patients vs 154 controls). These studies found that
perioperative b-blockade reduced cardiac morbidity and
mortality in high-risk patients.19 20 Second, if PTCA with
stenting is performed before surgery, surgery should be
postponed for as long as possible and antiplatelet therapy
should be continued in the perioperative period. If this is
inappropriate and coronary intervention is indicated, we
suggest a two-step procedure: if surgery cannot be post-
poned for 3 months, preoperative revascularization could be
limited to a balloon angioplasty without stenting. Once the
patient has recovered from the non-cardiac operation, a
de®nitive PTCA with stenting could then be done. Because
intracoronary stenting has better short- and long-term
results compared with angioplasty without stenting, and
because no clinical data are available comparing the two
techniques in a perioperative setting, cardiologists may be
reluctant to apply this latter approach. Even if preoperative
coronary revascularization, with or without stenting, is
performed, these patients should still be considered as high
risk and could bene®t from perioperative b-blockade.
In conclusion, we describe a fatal myocardial infarction
in a patient with CAD who had major surgery for malignant
disease after coronary revascularization with PTCA and
stenting 6 weeks before this surgery. The AHA/ACC
guidelines recommend a 4±6-week interval between coron-
ary stenting and major non-cardiac surgery but this case
illustrates that a risk continues after this interval and that
additional aggressive antiplatelet therapy and haemody-
namic protective measures, such as b-blockade and optimal
pain control, are needed.
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